These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 7370100

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T, Katoh H, Noda SE, Ito K, Yamamoto T, Kashiwagi B, Nakano T.
    Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):472-8. PubMed ID: 16168839
    [Abstract] [Full Text] [Related]

  • 5. Dose-volume impact in high-dose-rate Iridium-192 brachytherapy as a boost to external beam radiotherapy for localized prostate cancer--a phase II study.
    Pinkawa M, Fischedick K, Treusacher P, Asadpour B, Gagel B, Piroth MD, Borchers H, Jakse G, Eble MJ.
    Radiother Oncol; 2006 Jan 01; 78(1):41-6. PubMed ID: 16271785
    [Abstract] [Full Text] [Related]

  • 6. [The recommendations of the International Commission on Radiological Protection (ICRP) for high-dose-rate brachytherapy and for permanent prostatic implants].
    Cosset JM, Pinillos-Ashton L, Mettler F, Comité 3 (Radioprotection en Médecine) de la Commission internationale de protection radiologique.
    Cancer Radiother; 2004 Nov 01; 8 Suppl 1():S50-5. PubMed ID: 15679247
    [Abstract] [Full Text] [Related]

  • 7. [Interstitial radiotherapy of prostatic carcinoma with 125-iodine. Radiation protection measures].
    Knüfermann H, Kuphal K, Wannenmacher M.
    Strahlentherapie Sonderb; 1978 Nov 01; 75():213-6. PubMed ID: 555051
    [No Abstract] [Full Text] [Related]

  • 8. [Measurement of the radiation load to bladder and rectum in gynecological brachytherapy with a mobile radiation source (author's transl)].
    Busch M.
    Strahlentherapie; 1978 Oct 01; 154(10):681-5. PubMed ID: 694958
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dosimetry accuracy as a function of seed localization uncertainty in permanent prostate brachytherapy: increased seed number correlates with less variability in prostate dosimetry.
    Su Y, Davis BJ, Furutani KM, Herman MG, Robb RA.
    Phys Med Biol; 2007 Jun 07; 52(11):3105-19. PubMed ID: 17505092
    [Abstract] [Full Text] [Related]

  • 11. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T, Ito K, Saitoh J, Noda SE, Harashima K, Sakurai H, Nakayama Y, Yamamoto T, Suzuki K, Nakano T, Niibe H.
    Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):463-71. PubMed ID: 16168838
    [Abstract] [Full Text] [Related]

  • 12. [Radiation therapy of prostatic carcinoma (author's transl)].
    Wannenmacher M.
    Strahlentherapie; 1980 Nov 01; 156(11):737-41. PubMed ID: 6776658
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Improvement of the radiological protection in the interstitial radiotherapy with radiogold seeds (author's transl)].
    Schmidt J.
    Strahlentherapie; 1981 Jan 01; 157(1):29-32. PubMed ID: 7210044
    [Abstract] [Full Text] [Related]

  • 16. An innovative dosimetric model for formulating a semi-analytical solution for the activity-volume relationship in prostate implants.
    Lee PC, Parks EK, Moran BJ.
    Med Dosim; 2003 Jan 01; 28(4):243-53. PubMed ID: 14684189
    [Abstract] [Full Text] [Related]

  • 17. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
    Yaparpalvi R, Mutyala S, Gorla GR, Butler J, Mah D, Garg MK, Kalnicki S.
    Brachytherapy; 2008 Jan 01; 7(4):336-42. PubMed ID: 18782683
    [Abstract] [Full Text] [Related]

  • 18. Rectal morbidity following I-125 prostate brachytherapy in relation to dosimetry.
    Ohashi T, Yorozu A, Toya K, Saito S, Momma T, Nagata H, Kosugi M.
    Jpn J Clin Oncol; 2007 Feb 01; 37(2):121-6. PubMed ID: 17255159
    [Abstract] [Full Text] [Related]

  • 19. [Physical and technical quality assurance and radiation protection in transperineal interstitial permanent prostate brachytherapy with 125-iodine seeds].
    Kaulich TW, Lamprecht U, Paulsen F, Lorenz J, Maurer U, Loeser W, Bichler KH, Nüsslin F, Bamberg M.
    Strahlenther Onkol; 2002 Dec 01; 178(12):667-75. PubMed ID: 12491054
    [Abstract] [Full Text] [Related]

  • 20. [Side effects from high voltage therapy of carcinoma of the prostate (author's transl)].
    Burchardt P, Franke HD, Klosterhalfen H, Zimmer R.
    Urologe A; 1973 Sep 01; 12(5):254-5. PubMed ID: 4202747
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.